Wishing you a Merry Christmas from HemexDx family! 🌟 This festive season, we celebrate not just the joy of Christmas but also the strides we are trying to make in transforming healthcare. Gazelle brings cutting-edge diagnostics to the point of care, making healthcare accessible for all communities. Let’s continue spreading hope, health, and happiness as we work towards a brighter, healthier future for everyone. #MerryChristmas #SeasonOfGiving #HemoglobinopathyDiagnosis #SickleCellAnemia #BetaThalassemia #Gazelle #HealthForAll
Hemex Health, Inc.
医疗设备制造业
Portland，OR 5,559 位关注者
Diagnostics that empower the new front lines of healthcare
关于我们
Hemex Health focuses on commercializing proven research into cost-effective, intuitive devices optimized to make diagnostics more accessible at the front lines of healthcare. Our products are designed to be easy to use and provide benefit quickly and effectively for the healthcare worker and patient on the ground, at the point-of-need. The company’s leaders, with backgrounds in international business and biomedical engineering, have decades of success in developing and delivering more than 60 products that have made a difference in people’s lives. We leverage our experience in building successful medical products to solve major needs in global health. Our low-cost technologies are targeted for the developing world and can impact millions by identifying diseases which can be affordably treated. Hemex is developing a diagnostic platform (utilizing technology which received a 2016 Patents for Humanity Award) that can quickly and easily diagnose hemoglobin disorders, such as sickle cell disease and beta thalassemia, from a drop of blood. The solution provides point-of-care access to diagnostic information faster, more cost-effectively, and more accurately than any solution on the market today. Hemex is an equal opportunity employer. All employment-related decisions are based solely upon one’s individual merit and qualifications directly related to professional competence, and without regard to race, color, religion, national origin, pregnancy status, sex (gender}, age, marital status, mental or physical disability, sexual orientation, gender identity, military or veteran status, genetic history, or any other characteristic or classification protected by applicable law. We will also attempt to reasonably accommodate an individual based on his/her physical or mental limitation or because of the individual’s sincerely held religious beliefs.
- 网站
-
http://www.hemexhealth.com
Hemex Health, Inc.的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 51-200 人
- 总部
- Portland，OR
- 类型
- 私人持股
- 创立
- 2016
- 领域
- Diagnostics、Sickle Cell Disease和Beta Thalassemia
地点
-
主要
获取路线
4640 SW Macadam Avenue
Suite 250
US，OR，Portland，97239
Hemex Health, Inc.员工
-
Peter Galen
Supporting new technologies and affordable medical products, helping visionaries build companies.
-
Marc Manley
CEO of WVC. Building a better world through venture capital investments in science & tech startups.
-
Gerrit J. van Roekel
Vice President of Business Development at Hemex Health, Inc.
-
Susan R. Hart, PMP
Director Regulatory & Quality Affairs at Hemex Health, Inc.
动态
-
We are honored that Dr. Samuel Misiani Mbunya, BMS, PgDRes, MBA, DBA selected Gazelle to help spread the word about SCD and early diagnosis. We share his passion for spreading the knowledge on SCD and glad Gazelle can be a tool right at point of care. #SickleCellDisease #gazelle #healthEducation
💫 Exciting news! We proudly handed over a Gazelle to Dr. Samuel Misiani Mbunya, BMS, PgDRes, MBA, DBA of Dr. Sam Mbunya Consultancy— a significant step forward in our shared mission to enhance advocacy and #sicklecell testing in remote areas across #Kenya. 🤝 Joining us in support were James Opere, Board Chairman of Sickle Cell Federation of Kenya ., and Bruce Mutua of Crown Healthcare. Together, we’re making strides for those affected by sickle cell disease! #HealthcareInnovation #CommunityImpact
-
-
Hemex is honored to be an innovation partner with CARE. It was great to meet Dolly Kovvali and Sushila Varma in person this week in Hyderabad, India and to plan how we can work together for greater impact. Thanks also to Sarvesh Singh for helping us as our mentor in the T-Hub Social Impact Business Accelerator. #healthimpact #Gazelle #SickleCellDisease #HemexDX Anshul Srivastava
-
-
💫 The 66th American Society of Hematology Annual Meeting has officially wrapped up, and Hemex Health had an amazing time connecting with the global hematology community! A big thank you to everyone who attended, participated in discussions, and contributed to making the meeting a success. We are excited to continue working together to drive patient screenings and improve health outcomes around the world. We were proud to see the latest findings from studies conducted in Türkiye and India highlighting the accuracy and value of our Gazelle® device in national health initiatives focused on hemoglobinopathies, including sickle cell disease and beta thalassemia. For more details, check out our press release here: https://bit.ly/4fbZt7P #ASH2024 #SickleCellDisease #Thalassemia #Gazelle #Hematology #HealthInnovation
-
-
We presented our recent clinical validation study for using Hemex Health, Inc. Gazelle in premarital #thalassemia and #hemoglobinopathy screening in Turkiye 🇹🇷, a study led by Duran Canatan of Antalya Genetik Hastalıklar Tanı Merkezi. #ASH24 Gazelle is now registered in Turkiye and it will soon be available in clinics and labs, small and large. Thank you Pankaj Qasba of National Heart, Lung, and Blood Institute for stopping by. Our work on sickle cell disease and thalassemia would not have been possible without the support of #NHLBI! Also, thank you Stephanie M. Davis, Ph.D. for supporting translational research and commercialization in hematology and blood disorders.
-
-
🗓️ ASH Meeting Attendees, we're excited to invite you to visit poster #3621, "Identification of Diverse Hemoglobinopathies in India", today, December 8 from 6-8 PM! Research highlights Gazelle's accuracy when used in screening for hemoglobin variants in high-prevalence regions of West Bengal and Odisha. This is especially relevant as a tool to support the National Sickle Cell Anemia Elimination Mission (NSCAEM), focused on tackling SCD across India. 🇮🇳 Don’t miss it! #ASH2024 #SickleCell #thalassemia #Gazelle #PublicHealth #India #NSCAEM https://lnkd.in/gz5KvFJn
-
Attention ASH Attendees! Join us today at Poster 1094, from 5:30–7:30 PM, to explore Gazelle data from Türkiye. 🇹🇷 Key findings: ✅ Gazelle's performance in identifying SCD and beta thalassemia is on par with HPLC, helping facilitate consistent and accurate diagnoses. ✅ Gazelle is a useful tool to support Türkiye's national beta thalassemia prevention program, a crucial initiative aimed at boosting premarital screening rates in provinces with high disease prevalence. Don’t miss this opportunity to learn more about how Gazelle can offer utility in public health programs worldwide! #ASH2024 #SickleCellDisease #BetaThalassemia #HealthInnovation #PublicHealth #Gazelle #Türkiye https://lnkd.in/gKqn3ppw
1094 A New Diagnostic Method for Premarital Screening of Thalassemia and Hemoglobinopathies: Microchip Electrophoresis (Gazelle) Method
ash.confex.com
-
We are excited to announce that data will be presented on the effectiveness of the Gazelle™ Diagnostic Device at the 66th American Society of Hematology (ASH) Annual Meeting this week in San Diego! 💥 Studies from Türkiye and India highlight the accuracy and value of Gazelle in national health initiatives focused on hemoglobinopathies, including sickle cell disease (SCD) and beta thalassemia. 📍 Visit us at ASH: Poster 1094 (Türkiye Study): Dec 7, 5:30–7:30 PM Poster 3621 (India Study): Dec 8, 6:00–8:00 PM #ASH2024 #Hemoglobinopathies #SickleCellDisease #Thalassemia #PublicHealth #GlobalHealth
-
-
JOHN KEEN, our Business Development Manager for Africa, recently had the privilege of attending a Stakeholders Engagement and Site Assembly in Taita Taveta County, Kenya. A big thank you to Lea Kilenga Bey, CEO of the Africa Sickle Cell Organization (ASCO), and her team, for the opportunity to collaborate in discussions on improving the well-being of people impacted by sickle cell across the region. 🙏 The assembly offered the opportunity to meet with Gifton Mkaya, Officer at the Taita Taveta County Ministry of Medical Services, and Dr. Hiram Mwangi Medical Affairs for Terumo Blood and Cell Technologies. Visiting at Mwatate Sub County Hospital and sickle cell clinic allowed for a first-hand view of the work being done to support sickle cell patients. Hemex is committed to continued collaboration and strong partnerships that will improve diagnostic access for people with sickle cell and lead to better health outcomes. 📈 #SickleCellAwareness #AfricaSickleCellOrganization #PublicHealth #SickleCell #MwatateHospital
-
-
Gazelle distributor LIFECARE TECHNOLOGIES SARL recently provided a training for healthcare workers at the Sickle Cell Research and Treatment Centre (CRTD), located on the grounds of Bangui’s National University Hospital Centre in the Central African Republic. Founded in 2018 by the Ministry of Health and Population, CRTD specializes in treatment of #SickleCellDisease, providing crucial care and essential treatment. 🩸 Thank you to Dr. Jean Paul of LifeCare for working to make life-changing diagnostics available in the #CentralAfricanRepublic! 🙏
-